A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Gout can be successfully managed in these people with consideration of the influence of medications used for gout and their impact on the components of the metabolic syndrome and on chronic renal ...

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

It is estimated that more than 5.6 million people in the UK are living with diabetes, with 90 per cent suffering from type 2 ...

"This class of drugs may be a useful addition to the current treatments for nephrolithiasis to simultaneously tackle the high ...

Men from all over Atlanta gathered for the annual Men’s Appreciation event, hosted by Yung Joc and PGA Associate Kent Buckner ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning, ladies and gentlemen, and welcome to the Protalix ...

When it comes to weight loss journeys, we often focus on before-and-after photos and diet tips. But what happens when your ...